Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-EN Version v11-FR
Language English French
Date Updated 2024-02-27 2024-02-26
Drug Identification Number 02245676 02245676
Brand name ESTRADOT 25 ESTRADOT 25
Common or Proper name ESTRADOT 25 ESTRADOT 25
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients ESTRADIOL ESTRADIOL
Strength(s) 25MCG 25MCG
Dosage form(s) PATCH PATCH
Route of administration TRANSDERMAL TRANSDERMAL TRANSDERMAL TRANSDERMAL
Packaging size 8TTS 8TTS
ATC code G03CA G03CA
ATC description ESTROGENS ESTROGENS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-01-03 2024-01-03
Estimated end date 2024-02-23 2024-02-23
Actual end date 2024-02-26 2024-02-26
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments